FTF Martin Currie US Unconstrained Fund Class W AccumulationRegister to Unlock Ratings |
Performance History | 30/04/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 25.0 | 25.4 | -28.0 | 20.2 | 7.3 | |
+/-Cat | -6.2 | 3.5 | -6.5 | -6.5 | -0.2 | |
+/-B’mrk | -6.9 | -2.0 | -4.8 | -11.9 | -1.5 | |
Category: US Large-Cap Growth Equity | ||||||
Category Benchmark: Morningstar US LM Brd Growt... |
Key Stats | ||
NAV 08/05/2024 | GBP 8.01 | |
Day Change | -0.14% | |
Morningstar Category™ | US Large-Cap Growth Equity | |
IA (formerly IMA) Sector | North America | |
ISIN | GB00BP9LKG43 | |
Fund Size (Mil) 13/09/2022 | GBP 150.70 | |
Share Class Size (Mil) 08/05/2024 | GBP 117.61 | |
Max Initial Charge | - | |
Ongoing Charge 06/02/2024 | 0.82% |
Investment Objective: FTF Martin Currie US Unconstrained Fund Class W Accumulation |
The Fund aims to grow in value over five years or more after all fees and costs are deducted. The Fund invests at least 80% of its assets in shares of US companies. The Fund typically invests in shares of around 20-40 companies of any size, industry or market capitalisation, although the Investment Manager may invest in fewer or more companies where it considers this to be in the interests of the Fund. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Zehrid Osmani 20/12/2019 | ||
Robbie McNab 08/07/2019 | ||
Inception Date 23/09/2022 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI USA NR GBP | Morningstar US LM Brd Growth NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for FTF Martin Currie US Unconstrained Fund Class W Accumulation | 31/03/2024 |
|
|
Top 5 Holdings | Sector | % |
Microsoft Corp | Technology | 9.52 |
NVIDIA Corp | Technology | 9.45 |
Linde PLC | Basic Materials | 7.77 |
ResMed Inc | Healthcare | 6.98 |
Illumina Inc | Healthcare | 5.77 |
Increase Decrease New since last portfolio | ||
FTF Martin Currie US Unconstrained Fund Class W Accumulation |